For: |
Li QT, Kang W, Wang M, Yang J, Zuo Y, Zhang W, Su DK. Association between esophageal cancer risk and |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i17/5124.htm |
Number | Citing Articles |
1 |
Kholood Abid Janjua, Raheem Shahzad, Adeeb Shehzad. Cancer Biomarkers in Diagnosis and Therapeutics. 2022; : 277 doi: 10.1007/978-981-16-5759-7_11
|
2 |
Hui Cheng, Chongmei Huang, Gusheng Tang, Huiying Qiu, Lei Gao, Weiping Zhang, Jianmin Wang, Jianmin Yang, Li Chen. Emerging role of EPHX1 in chemoresistance of acute myeloid leukemia by regurlating drug‐metabolizing enzymes and apoptotic signaling. Molecular Carcinogenesis 2019; 58(5): 808 doi: 10.1002/mc.22973
|
3 |
Jie Tian, Caiyang Liu, Guanchu Liu, Chunjian Zuo, Huanwen Chen. Cumulative evidence for association between genetic polymorphisms and esophageal cancer susceptibility: A review with evidence from meta‐analysis and genome‐wide association studies. Cancer Medicine 2019; 8(3): 1289 doi: 10.1002/cam4.1972
|
4 |
Dabao He, Hengfeng Tang, Xiaoling Yang, Xiaohong Liu, Yipeng Zhang, Junzhu Shi. Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1278496
|
5 |
Ying Jin.
Association between
EPHX1
polymorphism rs1051740 and the risk of ovarian cancer: a meta-analysis
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 2338 doi: 10.1080/21691401.2019.1622551
|
6 |
Wanli Yang, Yu Han, Xinhui Zhao, Lili Duan, Wei Zhou, Xiaoqian Wang, Gaokai Shi, Yinggang Che, Yujie Zhang, Jinqiang Liu, Hongwei Zhang, Qingchuan Zhao, Liu Hong, Daiming Fan. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019; 19(2): 109 doi: 10.1080/14737159.2019.1563485
|